Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana C Parente-Pereira

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Biology|March 27, 2024
Engineering a Dual Specificity γδ T-Cell Receptor for Cancer ImmunotherapyDavid M Davies, Giuseppe Pugliese, Ana C Parente Pereira, et al.
Cancers|May 17, 2019
CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid MalignanciesLynsey M Whilding, Leena Halim, Benjamin Draper, et al.
STAR Protocols|May 2, 2022
Generation and application of TGFβ-educated human Vγ9Vδ2 T cellsAna C Parente-Pereira, Richard E Beatson, David M Davies, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 25, 2016
In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in miceNaomi O Hodgins, Wafa' T Al-Jamal, Julie T-W Wang, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 9, 2011
Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorderAna C Parente Pereira, Andrew McQuillin, Vinay Puri, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 2018
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancerJohn Wahba, Marina Natoli, Lynsey M Whilding, et al.
Advanced Healthcare Materials|April 14, 2015
Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killingPei Yun Teo, Chuan Yang, Lynsey M Whilding, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 16, 2018
In Vivo PET Tracking of <sup>89</sup>Zr-Labeled Vγ9Vδ2 T Cells to Mouse Xenograft Breast Tumors Activated with Liposomal AlendronateFrancis Man, Lindsay Lim, Alessia Volpe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 31, 2013
Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with CarboplatinAna C Parente-Pereira, Lynsey M Whilding, Nancy Brewig, et al.
Cancer Letters|February 23, 2017
Intracavitary 'T4 immunotherapy' of malignant mesothelioma using pan-ErbB re-targeted CAR T-cellsAstero Klampatsa, Daniela Y Achkova, David M Davies, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Biology|March 27, 2024
Engineering a Dual Specificity γδ T-Cell Receptor for Cancer ImmunotherapyDavid M Davies, Giuseppe Pugliese, Ana C Parente Pereira, et al.
Cancers|May 17, 2019
CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid MalignanciesLynsey M Whilding, Leena Halim, Benjamin Draper, et al.
STAR Protocols|May 2, 2022
Generation and application of TGFβ-educated human Vγ9Vδ2 T cellsAna C Parente-Pereira, Richard E Beatson, David M Davies, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 25, 2016
In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in miceNaomi O Hodgins, Wafa' T Al-Jamal, Julie T-W Wang, et al.
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|February 9, 2011
Genetic association and sequencing of the insulin-like growth factor 1 gene in bipolar affective disorderAna C Parente Pereira, Andrew McQuillin, Vinay Puri, et al.
Cancer Immunology, Immunotherapy : CII|September 1, 2018
Chemotherapy-induced apoptosis, autophagy and cell cycle arrest are key drivers of synergy in chemo-immunotherapy of epithelial ovarian cancerJohn Wahba, Marina Natoli, Lynsey M Whilding, et al.
Advanced Healthcare Materials|April 14, 2015
Ovarian cancer immunotherapy using PD-L1 siRNA targeted delivery from folic acid-functionalized polyethylenimine: strategies to enhance T cell killingPei Yun Teo, Chuan Yang, Lynsey M Whilding, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 16, 2018
In Vivo PET Tracking of <sup>89</sup>Zr-Labeled Vγ9Vδ2 T Cells to Mouse Xenograft Breast Tumors Activated with Liposomal AlendronateFrancis Man, Lindsay Lim, Alessia Volpe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 31, 2013
Synergistic Chemoimmunotherapy of Epithelial Ovarian Cancer Using ErbB-Retargeted T Cells Combined with CarboplatinAna C Parente-Pereira, Lynsey M Whilding, Nancy Brewig, et al.
Cancer Letters|February 23, 2017
Intracavitary 'T4 immunotherapy' of malignant mesothelioma using pan-ErbB re-targeted CAR T-cellsAstero Klampatsa, Daniela Y Achkova, David M Davies, et al.
Pageof 3